Skip to main content
. 2023 Sep 6;182(11):5087–5093. doi: 10.1007/s00431-023-05179-7

Table 2.

Use of medications for MIS-C

Yes, % (n) No, % (n) Not available, % (n)
Steroids 79.1% (53) 17.9% (12) 3% (2)
IVIGS 69.6% (48) 30% (20) 1.5% (1)
ASA 48.5% (32) 50% (33) 1.5% (1)
Anakinra 27.9% (19) 70.6% (48) 1.5% (1)

IVIGs intravenous immunoglobulins, ASA acetylsalicylic acid